M3 (2413) · InitiativeRestated
Collaboration with Sony in Healthcare and Health-Related Fields
First written in FY2021. 2 of 3 entries say "Restated". Latest entry: FY2023.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Collaboration with Sony in Healthcare and Health-Related FieldsA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2023RestatedAnnual report
「同社と当社との間には医療・ヘルスケア領域における協業に関する取引がありますが、同社と当社との間の年間取引額が当社及び同社の連結売上高に占める比率はいずれも１％未満であります。」
ソニーグループとの医療・ヘルスケア領域の協業関係を継続して開示している。 - FY2022RestatedAnnual report
「同社と当社との間には医療・ヘルスケア領域における協業に関する取引がありますが、同社と当社との間の年間取引額が当社及び同社の連結売上高に占める比率はいずれも１％未満であります。」
ソニーグループとの医療・ヘルスケア領域の協業およびCOVID-19対策に係る関係を継続して開示している。 - FY2021First statedAnnual report
「In addition to receiving a donation from the company for collaboration on measures against COVID-19, our Company and the company have transactions relating to collaboration in healthcare and health-related fields. However, the annual transaction value between the two companies represents less than 1% of the consolidated revenue of both our Company and the company.」
The Group initially disclosed its collaboration with the Sony Group in healthcare and health-related fields, including a donation for COVID-19 measures, as a specific business relationship.